Compared with para‐carcinoma samples, clinical RCC samples presented lower full‐length ITM2B levels but maintained high ITM2B truncation levels, further supporting the protumoral role of ITM2B truncation. The gene discussed is ITM2B; the disease is renal cell carcinoma.